Sign In
Buy BBIO
$65.48
+1.60 (+2.50%)
At Close: Jun 03, 2026
Hedge Funds Are Nibbling On BridgeBio Pharma, Inc. (BBIO)
07:43pm, Sunday, 05'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Convertir la bière périmée en alcool, une idée bruxelloise
04:43pm, Wednesday, 01'st Jul 2020
La période de lockdown a vu des fûts de bière stagner dans les bars fermés, jusqu'à arriver à péremption. Des brasseurs bruxellois en ont fait de l'eau de vie.
Benzinga's Top Upgrades, Downgrades For June 25, 2020
02:10pm, Thursday, 25'th Jun 2020
Upgrades * Credit Suisse changed the rating for Allstate Corp (NYSE: ALL) from Underperform to Neutral. Allstate earned $3.54 in the first quarter, compared to $2.30 in the year-ago quarter. The sto
BridgeBio Pharma, Inc. Appoints Biotech Trailblazers Brent Saunders and Randy Scott and Renowned Economist Andrew Lo to Board of Directors
11:30am, Wednesday, 24'th Jun 2020
BridgeBio Pharma, Inc. (BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, today announced that it has added three new independent directors to its board: former Allergan C
BridgeBio Pharma (BBIO) Investor Presentation - Slideshow
04:12pm, Tuesday, 23'rd Jun 2020Xconomy: Diversity & Inclusion Events Have Halted. Our Conversations Shouldn’t.
10:00am, Monday, 22'nd Jun 2020
If the state of current events has shown us one thing, it’s that inclusion matters. Inclusivity is more important than ever. Whether you are black, white,
Victory Capital Management Inc. Decreases Stock Position in BridgeBio Pharma (NASDAQ:BBIO)
04:46am, Monday, 22'nd Jun 2020
Victory Capital Management Inc. lessened its holdings in BridgeBio Pharma (NASDAQ:BBIO) by 3.7% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. T
BridgeBio Pharma and University of Florida Establish Collaboration to Advance Therapies for Genetically Driven Diseases
11:35am, Thursday, 18'th Jun 2020
BridgeBio Pharma, Inc. (BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, has entered into a strategic collaboration with the University of Florida to translate research i
BridgeBio Pharma, Inc. (BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, today announced that it has entered into a collaboration agreement with Johns Hopkins University
Alle schulden met een toverstokje uitwissen?
12:00am, Wednesday, 17'th Jun 2020
Obligaties Analyses door Oblis over: XAU/USD, Futures goud. Lees Oblis's Obligaties Analyses op Investing.com.
BridgeBio Pharma, Inc. (BBIO) affiliate ML Bio Solutions today announced that the first subject has been dosed in the Phase 1 clinical trial of BBP-418, an orally-administered small molecule therapy b
Erdogan Eyes Converting Hagia Sophia into a Mosque Again
09:01pm, Wednesday, 10'th Jun 2020
Turkish President Recep Tayyip Erdogan is once again exploring ways to convert the Hagia Sophia Museum in Istanbul into a mosque.
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2020 Update
02:39pm, Monday, 08'th Jun 2020
Halvorsen's 13F portfolio value decreased from $21.35B to $19.21B. The number of positions decreased from 66 to 64. Viking Global increased Comcast, Fidelity Na
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30pm, Friday, 05'th Jun 2020
PALO ALTO, Calif., June 05, 2020 -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, today announced that on June.
7 Growth Stocks to Buy for Oodles of Upside
06:43pm, Friday, 05'th Jun 2020
Stocks are firing on all cylinders again and have clawed back most of their bear-market losses. But investors fearing that all of the high-upside opportunities have passed them by can breathe easy. Th
